Survival of AML patients relapsing after allogeneic hematopoietic cell transplantation: a CIBMTR study

Acute myeloid leukemia (AML) relapse after allogeneic hematopoietic cell transplantation (alloHCT) remains a major therapeutic challenge. We studied outcomes of 1788 AML patients relapsing after alloHCT (1990–2010) during first or second complete remission (CR) to identify factors associated with lo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Biol Blood Marrow Transplant
Autores principales: Bejanyan, Nelli, Weisdorf, Daniel J., Logan, Brent R., Wang, Hai-Lin, Devine, Steven M., de Lima, Marcos, Bunjes, Donald W., Zhang, Mei-Jie
Formato: Artigo
Lenguaje:Inglês
Publicado: 2014
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4329076/
https://ncbi.nlm.nih.gov/pubmed/25460355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.11.007
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares